+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Anaphylaxis Treatment Market Report 2025 - Product Thumbnail Image

Anaphylaxis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Inflammatory Bowel Disease Treatment Market Report 2025 - Product Thumbnail Image

Inflammatory Bowel Disease Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Tyrosine Kinase Inhibitors Market 2025-2029 - Product Thumbnail Image

Tyrosine Kinase Inhibitors Market 2025-2029

  • Report
  • December 2024
  • 195 Pages
  • Global
From
From
Migraine Drugs - Global Strategic Business Report - Product Thumbnail Image

Migraine Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 193 Pages
  • Global
From
Coronary Artery Disease Market Report 2025 - Product Thumbnail Image

Coronary Artery Disease Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Gene Editing Therapeutics Market - Product Thumbnail Image

Gene Editing Therapeutics Market

  • Report
  • August 2024
  • 111 Pages
  • Global
From
Investor Series: Opportunities in the Telehealth Market - Product Thumbnail Image

Investor Series: Opportunities in the Telehealth Market

  • Report
  • January 2022
  • 341 Pages
  • Global
From
Cancer Therapies - Global Strategic Business Report - Product Thumbnail Image

Cancer Therapies - Global Strategic Business Report

  • Report
  • April 2025
  • 590 Pages
  • Global
From
From
From
From
Loading Indicator